This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignees: Chinese Academy of Sciences, Shanghai Institute of Pharmaceutical Industry. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2014
Title: Jue Hu - Innovator in Anti-HCV Medicaments
Introduction
Jue Hu is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-HCV medicaments. His innovative approach combines traditional Chinese medicine with modern pharmaceutical practices.
Latest Patents
Jue Hu holds a patent for the use of 9,10-anthraquinone compounds. This patent, which is titled "Use of 9,10-anthraquinone compounds," discloses the application of these compounds or their pharmaceutical salts in the preparation of anti-HCV medicaments. The compounds are recognized for being cost-effective, safe, and effective, primarily derived from traditional Chinese medicines. They exhibit better anti-HCV effects with lighter side effects.
Career Highlights
Throughout his career, Jue Hu has worked with esteemed institutions such as the Chinese Academy of Sciences and the Shanghai Institute of Pharmaceutical Industry. His work has been instrumental in advancing the understanding and treatment of HCV.
Collaborations
Jue Hu has collaborated with notable colleagues, including Shuguang Wang and Changlong Zhuang. Their combined expertise has contributed to the success of their research and innovations.
Conclusion
Jue Hu's contributions to the field of pharmaceuticals, particularly in anti-HCV medicaments, highlight his innovative spirit and dedication to improving healthcare. His work continues to influence the development of effective treatments derived from traditional practices.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile